🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Gram(s) Serving Size
50 Servings
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 250.0mg (1 products) 📚 6 studies (Tier A: 0, B: 2)
This product: 1mg

Other Ingredients

None

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take 1 scoop daily with 8-12 oz of water or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Warning: For healthy individuals 18 years and older.

Consult a healthcare professional prior to use if you are pregnant or nursing, taking medication, or have a medical condition.

Keep out of reach of children.

Do not use if safety seal is broken or missing.

🧪 Formulation Notes

Nicotinamide Monocleotide 1 g per serving

Additional Information

Notice: Store in a cool, dry place.

Quality Guaranteed Nutricost

Product Details

UPC / SKU 8 10014 67334 9
DSLD Entry Date 2022-06-16
Product Type Non-Nutrient/Non-Botanical
Form Powder
Brand Nutricost
DSLD ID 270614
Data Updated 2026-04-11

Research Evidence

8 Research Sources
54 Avg Quality Score
4 Rct
2 Meta Analysis
2 Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.)
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →

Compare Similar Products

View all Nmn products →